Home › Fabry Disease › Alabama › Birmingham
Fabry Disease clinical trials in Birmingham, AL
5 studies for Fabry Disease are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease
RecruitingPhase 3
- University of Alabama of Birmingham, Birmingham
A Study of Patients With Fabry Disease (US Specific)
RecruitingObservational study
- UAB Nephrology Research Clinic at Paula Building, Birmingham
Fabry Disease Registry & Pregnancy Sub-registry
RecruitingObservational study
- University Of Alabama Birmingham- Nephrology- Site Number : 840073, Birmingham
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
RecruitingPhase 1/2
- The Kirklin Clinic Of University of Alabama Birmingham Hospital, Birmingham
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
RecruitingObservational study
- University of Alabama at Birmingham, Birmingham
Fabry Disease trials in other cities
- Atlanta, GA7 studies
- Arlington, VA6 studies
- Minneapolis, MN5 studies
- Cincinnati, OH4 studies
- Pittsburgh, PA4 studies
- Chicago, IL4 studies
- Salt Lake City, UT3 studies
- Cedar Rapids, IA3 studies
- Dallas, TX3 studies
- New York City, NY3 studies
- Philadelphia, PA3 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Ovarian Cancer25 studies
- Breast Cancer24 studies
- Non-Small Cell Lung Cancer23 studies
- Obesity22 studies
- Acute Myeloid Leukemia21 studies
- COPD17 studies
- Multiple Myeloma17 studies
- Cardiovascular Disease16 studies
- Endometrial Cancer16 studies
- Overweight16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.